Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$51.77 - $66.18 $2.02 Million - $2.58 Million
-39,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $778,050 - $1.52 Million
39,000 New
39,000 $1.32 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Apis Capital Advisors, LLC Portfolio

Follow Apis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apis Capital Advisors, LLC with notifications on news.